N/A
Manufactured by Civica, Inc.
34,048 FDA adverse event reports analyzed
Last updated: 2026-04-14
FENTANYL CITRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Civica, Inc.. The most commonly reported adverse reactions for FENTANYL CITRATE include DEPENDENCE, OVERDOSE, DEATH, DRUG ABUSE, TOXICITY TO VARIOUS AGENTS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for FENTANYL CITRATE.
Out of 17,548 classified reports for FENTANYL CITRATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 34,048 FDA FAERS reports that mention FENTANYL CITRATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DEPENDENCE, OVERDOSE, DEATH, DRUG ABUSE, TOXICITY TO VARIOUS AGENTS, ILL-DEFINED DISORDER. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Civica, Inc. in connection with FENTANYL CITRATE. Always verify the specific product and NDC with your pharmacist.